The XPORT-EC-042 study is open to recruitment in Australia, after Border Medical Oncology Research Unit and Peter MacCallum Cancer Centre were activated. The trial is led by Karyopharm Therapeutics (Global Sponsor), in collaboration with ANZGOG, European [...]
SOLACE2 has achieved complete accrual, thanks to the 114 women across Australia who have generously participated, and the Investigators and staff at 15 sites in QLD, NSW, VIC, TAS and SA dedicated to the trial. [...]
As part of our commitment to member education, ANZGOG this week presented a two-part Education Webinar Series for ANZGOG members and others across the health sector on endometrial cancer. 267 people who registered for the [...]
Nine ovarian cancer advocates call for increased funding, research and awareness in a new podcast aimed at reducing stigma around gynaecological cancers, which launches on World Ovarian Cancer Day and Mother’s Day – Sunday, 8 May [...]
A new journal has recently been published by ASCO Journal of Clinical Oncology for TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Member. ANZGOG [...]
ANZGOG's ADELE study is a randomised phase 2 trial that aims to improve outcomes for women with high-risk endometrial cancer. Led by Principal Investigator Prof Linda Mileshkin & co-chair Dr Yeh Chen Lee, the [...]
The TIPS study is comparing the effectiveness of two different interventions given around the time of surgery for ovarian cancer to see if they improve the time needed to recover after surgery. Led by ANZGOG [...]
The AtTEnd clinical trial is for women with advanced stage or recurrent endometrial cancer and will assess whether the use of the immune therapy atezolizumab is of additional benefit to current, first line chemotherapy combination. [...]
The AtTEnd clinical trial is for women with advanced stage or recurrent endometrial cancer and will assess whether the use of the immune therapy atezolizumab is of additional benefit to current, first line chemotherapy combination. [...]
Dr Viet Do is an experienced clinical researcher in the gynaecological cancer space. As an ANZGOG member and Director of Radiation Oncology at SWSLHD at Liverpool and Campbelltown Hospitals, Dr Do is passionate about educating future [...]
Australia New Zealand Gynaecological Oncology Group www.anzgog.org.au
Level 6, Lifehouse, 119-143 Missenden Road Camperdown NSW 2050 T:+61 2 8071 4880
E: contact@anzgog.org.au © 2024 ANZGOG | Copyright | Disclaimer | ANZGOG Policies | Whistleblower
Virtually every advance in cancer survival has been made on the back of clinical trials.
As the peak, national gynaecological cancer clinical trials organisation for Australia and New Zealand, ANZGOG‘s purpose is to improve outcomes and quality of life for women with gynaecological cancer by conducting research.
We conduct and promote clinical trials and undertake multidisciplinary research into the causes, prevention and treatments of gynaecological cancers.
Research Community Volunteers will have the opportunity to contribute to ANZGOG research at every stage of the development process.
Community volunteers will lend their voices to research discussions sharing their personal perspective and representing the broader views of people with lived experience of gynaecological cancer.
Opportunities range from sharing your lived experience as a participant on a research grant working party or a Trial Management Committee, through to Research Advisor and Expert roles requiring additional levels of education and expertise in research analysis.
Gynaecological cancer research is critically needed but critically underfunded. WomenCan is the fundraising arm of ANZGOG, supporting ANZGOG by funding our programs to improve life for women with gynaecological cancer.
WomenCan’s mission is to engage the community to fund pioneering discoveries that will enable women with a gynaecological cancer to live better and live longer.
WomenCan believes the power of the collective, united in a common purpose, can make a real difference in the lives of women with gynaecological cancers.
ANZGOG’s Survivors Teaching Students (STS) Program is a ground-breaking volunteer program that brings gynaecological cancer survivors and caregivers into the classrooms of health professional students to teach them about women’s experiences with the diseases.
Survivors and caregivers are in a unique position to help students understand the ‘lived experience’ of a gynaecological cancer, including the psychosocial impact, and the importance of timely diagnosis, good health communication and compassionate care.
By joining STS and sharing your story, you will have the opportunity to impact the future care of women diagnosed with a gynaecological cancer, with participating students reporting not only increased understanding of gynaecological cancers but also a deeper understanding of the patient experience to take forward into their practice.
Since the program began at ANZGOG in 2017, our volunteers have shared their stories with more than 11,000 students across Australia and New Zealand.
